- Home
- CRDL vs TOYO Comparison
CRDL vs TOYO Comparison
Compare CRDL & TOYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRDL
- TOYO
- Stock Information
- Founded
- CRDL 2017
- TOYO 2022
- Country
- CRDL Canada
- TOYO Japan
- Employees
- CRDL N/A
- TOYO N/A
- Industry
- CRDL Biotechnology: Biological Products (No Diagnostic Substances)
- TOYO
- Sector
- CRDL Health Care
- TOYO
- Exchange
- CRDL Nasdaq
- TOYO NYSE
- Market Cap
- CRDL 125.7M
- TOYO 115.2M
- IPO Year
- CRDL N/A
- TOYO N/A
- Fundamental
- Price
- CRDL $1.28
- TOYO $3.37
- Analyst Decision
- CRDL Strong Buy
- TOYO
- Analyst Count
- CRDL 3
- TOYO 0
- Target Price
- CRDL $9.00
- TOYO N/A
- AVG Volume (30 Days)
- CRDL 391.0K
- TOYO 2.6M
- Earning Date
- CRDL 11-14-2024
- TOYO 02-21-2025
- Dividend Yield
- CRDL N/A
- TOYO N/A
- EPS Growth
- CRDL N/A
- TOYO N/A
- EPS
- CRDL N/A
- TOYO 0.76
- Revenue
- CRDL N/A
- TOYO $200,455,385.00
- Revenue This Year
- CRDL N/A
- TOYO N/A
- Revenue Next Year
- CRDL N/A
- TOYO N/A
- P/E Ratio
- CRDL N/A
- TOYO $4.42
- Revenue Growth
- CRDL N/A
- TOYO N/A
- 52 Week Low
- CRDL $0.79
- TOYO $1.36
- 52 Week High
- CRDL $3.12
- TOYO $15.61
- Technical
- Relative Strength Index (RSI)
- CRDL 26.78
- TOYO N/A
- Support Level
- CRDL $1.27
- TOYO N/A
- Resistance Level
- CRDL $1.46
- TOYO N/A
- Average True Range (ATR)
- CRDL 0.10
- TOYO 0.00
- MACD
- CRDL -0.00
- TOYO 0.00
- Stochastic Oscillator
- CRDL 3.33
- TOYO 0.00
About CRDL Cardiol Therapeutics Inc.
Cardiol Therapeutics Inc is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart diseases. The company's lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases. Cardiol has received Investigational New Drug Application authorization from the United States Food and Drug Administration to conduct clinical studies to evaluate the efficacy and safety of CardiolRx in two diseases affecting the heart which are a Phase II multi-national trial, the ARCHER trial, in acute myocarditis; and a Phase II multi-center open-label pilot study in recurrent pericarditis.
About TOYO TOYO CO LTD
Toyo Co Ltd along with its subsidiaries is engaged in research and development, production, and sales of solar cells.